AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 cr

AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 cr

PTIUpdated: Monday, August 09, 2021, 04:27 PM IST
article-image
AstraZeneca Pharma India had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal |

Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter.

The company had posted a net profit of Rs 18.63 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a regulatory filing.

Revenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago, it added.

The company's board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2021-22, the filing said.

Shares of AstraZeneca Pharma India closed at Rs 3,364.45 per scrip on BSE, down 1.23 per cent from its previous close

RECENT STORIES

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...

Amazon Rolls Out 10-Minute Delivery; Competition With Blinkit, Swiggy, Instamart & Zepto Intensifies

Amazon Rolls Out 10-Minute Delivery; Competition With Blinkit, Swiggy, Instamart & Zepto Intensifies

Shares Of Hindustan Unilever Surge 5% As Priya Nair Set To Become First Woman CEO & MD

Shares Of Hindustan Unilever Surge 5% As Priya Nair Set To Become First Woman CEO & MD

A Deep Dive Into India's Credit Landscape & The Journey Of A Financial Leader - Revati Kasture

A Deep Dive Into India's Credit Landscape & The Journey Of A Financial Leader - Revati Kasture

Kakinada SEZ Setting Up 3x50 MLD Desalination Plant In Andhra Pradesh Worth ₹1310 Crore

Kakinada SEZ Setting Up 3x50 MLD Desalination Plant In Andhra Pradesh Worth ₹1310 Crore